Literature DB >> 32470869

Anabolic steroids in myelodysplastic syndromes: A systematic review.

Alejandro Garcia-Horton1, Yashoda Valliere2, Alejandro Lazo-Langner3.   

Abstract

Entities:  

Keywords:  Anabolic steroid; Danazol; Myelodysplastic syndrome

Year:  2020        PMID： 32470869     DOI： 10.1016/j.leukres.2020.106370

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  1 in total

1.  Stanozolol improves the progression-free survival of patients with high-risk myelodysplastic syndrome after decitabine treatment.

Authors:  Yumei Liu; Chen Yang; Hua Xue; Fang Ye; Wanling Sun; Jingbo Wang; Weiwei Qi; Haiyue Niu; Luoming Hua; Huaquan Wang; Bing Han; Zonghong Shao
Journal:  Int J Hematol       Date:  2021-03-01       Impact factor: 2.490
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.